Thursday, 12 June 2025 | 15:30 - 16:00
ROUNDTABLE DISCUSSIONS Round 2: 1. Strategies for optimizing governance and decision making for life sciences programs
Location:Sierra Ballroom
- INNOVATIVE APPROACHES TO CONTEMPORARY CHALLENGES IN PHARMA & BIOTECH PPM
The significant financial investment required for drug development necessitates careful decision-making to balance innovation with financial viability. This discussion explores how implementing a robust decision making framework and governance structures ensures decisions are made based on robust data analysis, risk assessment, and a focus on patient safety.
1 speaker
Executive Director, Head of Program and Portfolio Management (PPM)
BioMarin Pharmaceuticals
Location image